The emergence of medications like copyright and Semaglutide signifies a major shift in how we manage type 2 diabetes. These groundbreaking therapies belong to a class known as GLP-1 receptor agonists, which mimic the effects of a natural hormone that manages glucose levels and food intake. Originally, developed for diabetes, their effectiveness in